Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

Log in to myENETS

ENETS Abstract Search

#3436 Prognostic factors in 382 patients treated with 177-Lu-DOTATATE: Data from the SEPTRALU registry

Introduction: The aim was to describe prognostic variables in patients treated with 177Lu-DOTATATE (PRRT).

Conference:

Presenting Author:

Authors: Pubul V, Belló P, Hernando J, Rodeño E, Gajate P,

Keywords: somatostatin receptor-positive tumor, PRRT, prognostic variables,

#1905 Pancreatic Neuroendocrine Tumors (pNETs): A Population-Based Analysis of Epidemiology and Outcomes.

Introduction: pNETs are rare and outcomes vary by stage, grade and presentation. The incidence and stage at diagnosis is changing

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: Westin G

Authors: Westin G, Alsidawi S, Hobday T, Halfdanarson T,

Keywords: Pancreatic NETs, survival,

#993 Analysis of Somatostatin Receptors Expression in Neuroendocrine Tumors

Introduction: Clinical studies have suggested anti-tumor efficacy of somatostatin analog (SSA) in the treatment of neuroendocrine tumors (NETs).

Conference: 11th Annual ENETSConcerence (2014)

Presenting Author: Li T

Authors: Li T, Qian Z, Ter-Minassian M, Chan J, Brais L,

Keywords: SSTR2, SSA, NET, OS, PFS,

#823 Association Between Tumor Expression of VEGFA, VEGFR1 (FLT1), VEGFR2 (KDR), and Clinical Outcomes in Neuroendocrine Tumors

Introduction: Clinical studies have suggested efficacy of VEGF pathway inhibitors in the treatment of advanced neuroendocrine tumors (NETs).

Conference: 11th Annual ENETSConcerence (2014)

Presenting Author: Qian Z

Authors: Qian Z, Ter-Minassian M, Chan J, Imamura Y, Hooshmand S,

Keywords: VEGF, bevacizumab, NET survival,